Literature DB >> 31077464

Conservative management in hypertriglyceridemia-associated pancreatitis.

A J Berberich1, A Ziada1, G Y Zou1, R A Hegele1.   

Abstract

BACKGROUND: Severe hypertriglyceridemia (serum triglyceride >10 mmol L-1 ) is implicated in ~9% of acute pancreatitis cases. Certain guidelines list severe hypertriglyceridemia as an indication for plasmapheresis.
OBJECTIVE: We assembled the natural trajectory of triglyceride levels in patients with acute pancreatitis due to severe hypertriglyceridemia who were managed conservatively without plasmapheresis to evaluate the effectiveness of this approach.
METHODS: A retrospective chart review was performed on 22 hospital admissions for acute pancreatitis episodes considered to be caused by severe hypertriglyceridemia. Patients were managed supportively, with cessation of oral intake (NPO) and intravenous hydration. Insulin infusion was used in 12 patients to manage concurrent hyperglycaemia.
RESULTS: Triglyceride levels for the group were evaluated using a mixed-effects model. The average triglyceride level fell from 45.4 mmol L-1 on presentation to 13.3 mmol L-1 within 48 h, corresponding to a mean 69.8% decrease. Regression analysis showed a triglyceride half-life of 30.6 h. Findings were similar for NPO-only and insulin infusion subgroups.
CONCLUSION: Patients with severe hypertriglyceridemia and acute pancreatitis can be conservatively managed safely and effectively without plasmapheresis.
© 2019 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  hypertriglyceridemia; insulin; pancreatitis; plasma exchange; plasmapheresis; triglycerides

Mesh:

Year:  2019        PMID: 31077464     DOI: 10.1111/joim.12925

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  14 in total

1.  A Modern Approach to Dyslipidemia.

Authors:  Amanda J Berberich; Robert A Hegele
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

Review 2.  The Diagnosis and Treatment of Hypertriglyceridemia.

Authors:  Klaus G Parhofer; Ulrich Laufs
Journal:  Dtsch Arztebl Int       Date:  2019-12-06       Impact factor: 5.594

3.  Dysregulated SREBP1c/miR-153 signaling induced by hypertriglyceridemia worsens acute pancreatitis and delays tissue repair.

Authors:  Juanjuan Dai; Mingjie Jiang; Yangyang Hu; Jingbo Xiao; Bin Hu; Jiyao Xu; Xiao Han; Shuangjun Shen; Bin Li; Zengkai Wu; Yan He; Yingchun Ren; Li Wen; Xingpeng Wang; Guoyong Hu
Journal:  JCI Insight       Date:  2021-01-25

Review 4.  Clinical review on triglycerides.

Authors:  Ulrich Laufs; Klaus G Parhofer; Henry N Ginsberg; Robert A Hegele
Journal:  Eur Heart J       Date:  2020-01-01       Impact factor: 29.983

5.  Total cholesterol concentration predicts the effect of plasmapheresis on hypertriglyceridemic acute pancreatitis: a retrospective case-control study.

Authors:  Zhu Chen; Xiaolong Huang; Na Han; Yanxia Guo; Jing Chen; Yaogui Ning; Minwei Zhang
Journal:  BMC Gastroenterol       Date:  2021-01-06       Impact factor: 3.067

6.  Genotype - phenotype correlation in an adolescent girl with pathogenic PPARy genetic variation that caused severe hypertriglyceridemia and early onset type 2 diabetes.

Authors:  Ana Gutierrez Alvarez; Naomi Yachelevich; Brenda Kohn; Preneet Cheema Brar
Journal:  Ann Pediatr Endocrinol Metab       Date:  2021-10-14

7.  Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion.

Authors:  Vishnu Priya Pulipati; Ambika Amblee; Sara Elizabeth T Yap; Hafeez Shaka; Bettina Tahsin; Leon Fogelfeld
Journal:  PLoS One       Date:  2021-11-30       Impact factor: 3.240

8.  Rapidly lowering triglyceride levels by plasma exchange in acute pancreatitis: What's the point?

Authors:  Amanda J Berberich; Robert A Hegele
Journal:  J Clin Apher       Date:  2022-02-23       Impact factor: 2.605

Review 9.  Genetics of Hypertriglyceridemia.

Authors:  Jacqueline S Dron; Robert A Hegele
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-24       Impact factor: 5.555

10.  Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.

Authors:  Jacqueline S Dron; Jian Wang; Adam D McIntyre; Michael A Iacocca; John F Robinson; Matthew R Ban; Henian Cao; Robert A Hegele
Journal:  BMC Med Genomics       Date:  2020-02-10       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.